TEM
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Tempus receives FDA clearance for its ECG-MR AI product designed to detect undiagnosed mitral regurgitationSep 28, 2026
- Tempus published a Nature Medicine study demonstrating best-in-class performance of PRISM2 across diagnostic and prognostic applicationsAug 4, 2026
- Tempus launches OneOme pharmacogenomic testing nationwide to advance precision medicineJul 22, 2026
- Tempus received FDA approval for Tumor Only xT CDx, enabling full migration of its DNA solid tumor portfolioMay 29, 2026
- Tempus launches ArteraAI prostate test for metastatic patients as the first clinical prostate digital pathology algorithm in its ecosystemMay 21, 2026